首页> 外文期刊>Journal of pediatric hematology/oncology: Official journal of the American Society of Pediatric Hematology/Oncology >Late presentation of opsoclonus-myoclonus-ataxia syndrome in a child with stage 4S neuroblastoma.
【24h】

Late presentation of opsoclonus-myoclonus-ataxia syndrome in a child with stage 4S neuroblastoma.

机译:儿童患有4S期神经母细胞瘤的晚期呈现opsoclonus-myoclonus-共济失调综合征。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Opsoclonus-myoclonus-ataxia syndrome (OMA) in children is most commonly associated with occult neuroblastoma (NB). Although children with OMA and NB have decreased mortality, they suffer from increased neurologic morbidity. The pathogenesis of OMA in NB is not well understood, but current research and treatments support an immune-mediated process. The authors describe an unusual presentation of OMA occurring following 6 months of chemotherapy in a child with stage 4S NB who presented with partial Horner syndrome. Histopathologic examination of his primary cervical tumor showed NB maturation, which may have played a role in precipitating OMA syndrome. Further study of unusual cases of OMA in NB may provide better understanding of the syndrome and additional treatment options for these children.
机译:儿童的Opsoclonus-myoclonus-共济失调综合征(OMA)最常与隐匿性神经母细胞瘤(NB)相关。尽管患有OMA和NB的儿童死亡率降低,但他们的神经系统疾病发病率却有所增加。 NB中OMA的发病机理尚不清楚,但是当前的研究和治疗方法支持免疫介导的过程。作者描述了在患有部分霍纳综合症的4S NB期儿童化疗6个月后发生的OMA异常​​表现。他的原发性宫颈肿瘤的组织病理学检查显示NB成熟,这可能是导致OMA综合征的原因。对NB中OMA异常​​病例的进一步研究可能会更好地了解这些综合征,并为这些儿童提供更多治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号